Cancer Science & Therapy
September 10-12, 2012 Hilton San Antonio Airport, USA
Participants List in Academia
Untitled Document
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
University Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
University di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-University Halle-Wittenberg, USA
University de Sao Paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
University Paris 13, France
Participants List From Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Womens Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddys labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria
Upcoming Conferences
2nd World Congress on Cancer Science & Therapy , will be organized around the theme "Emerging Trends in Cancer Science and Therapy."
Cancer Science-2012 is comprised of 11 tracks and 69 sessions designed to offer
comprehensive sessions that address current issues in Cancer Science & Therapy.
Submit your abstract to any of the following tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Track 1: Cancer Cell Biology
Track 1-1
Cancer stem cells and metastatic growth
Track 1-2
Cell to cell signaling and membrane proteins
Track 1-3
Inflammation and inflammatory factors in cancer development
Track 1-4
Metastatic cell growth and adhesion, apoptosis and cell division
Track 1-5
Cancer biology
Track 1-6
Tumor virology and pathology
Track 1-7
Cancer systems biology
Track 2: Diagnostic and Prognostic Cancer Biomarkers
Track 2-1
Biomarkers in cancer therapy and molecular diagnostics
Track 2-2
Genetic and DNA methylation-based biomarkers
Track 2-3
Prognostic biomarkers
Track 2-4
Biomarkers based on cancer types
Track 2-5
Biomarkers for cancer cell process
Track 2-6
Biomarkers for pathogenic process
Track 2-7
Biomarkers for pharmacologic responses
Track 3: Advances in Cancer Detection and Imaging
Track 3-1
Fluorescence imaging techniques
Track 3-2
Digital mammography and computer-aided detection system
Track 3-3
Electrical impedance scanning
Track 3-4
Nanotechnology based detection
Track 3-5
Tumor microarrays
Track 4: Cancer: Management & Prevention
Track 4-1
Diet and physical exercise
Track 4-2
Chemoprevention
Track 4-3
Cancer epidemiology and prevention
Track 4-4
DNA damage and repair
Track 5: Cancer Therapy
Track 5-1
Radiotherapy and chemotherapy
Track 5-2
Gene therapy and tumor immunity
Track 5-3
Hormone replacement therapy
Track 5-4
Molecular-targeted therapies
Track 5-5
Cancer: gene expression and protein profiling, surgery and laparoscopy
Track 5-6
Stem cells and cancer cell therapy
Track 5-7
Senescence induction
Track 5-8
Bacterial treatment
Track 5-9
Telomerase therapy
Track 5-10
Drug therapies
Track 6: Clinical Cancer Research
Track 6-1
Clinical medicine
Track 6-2
Targeting anticancer drugs
Track 6-3
Therapeutic targets in cancer
Track 6-4
Clinical research in cancer immunology
Track 6-5
Nanotechnology and novel drug delivery systems
Track 6-6
Therapeutic cancer vaccines
Track 6-7
Antioxidants as cancer preventive agent
Track 7: Carcinogenesis and Mutagenesis
Track 7-1
Metabolism of carcinogens
Track 7-2
Identification and detection of carcinogens
Track 7-3
Biological and external factors for carcinogenesis
Track 7-4
Mutagenesis- directed, site-specific and mismatched
Track 7-5
Environmental mutagenesis
Track 8: OMICS in Cancer Research
Track 8-1
High-throughput DNA sequencing technologies
Track 8-2
Operomics
Track 8-3
Bioinformatics
Track 8-4
Viral oncoproteomics
Track 9: Organ-Specific Cancers
Track 9-1
Head and brain cancer
Track 9-2
Nasopharyngeal, oral cavity, and thyroid cancers
Track 9-3
Neck, breast cancer, ovarian, and cervical cancer
Track 9-4
Oesophageal and gastrointestinal cancers
Track 9-5
Rectum, liver, cholecyst, and pancreatic cancer
Track 9-6
Bone,Leukemia, and myelodysplasia
Track 9-7
Lymphoma, melanoma skin cancer, and sarcomas
Track 9-8
Lung and prostate cancer
Track 9-9
Colorectal or colon cancers
Track 9-10
Urology, kidney/renal cancers
Track 9-11
Pediatric oncology
Track 10: Cancer Genetics
Track 10-1
Oncogenes
Track 10-2
Tumour suppressor genes
Track 10-3
Viruses and human cancer
Track 10-4
Genetics and toxicity
Track 10-5
Gene silencing and genome imprinting
Track 10-6
Gene silencing and RNA interference
Track 10-7
Non-coding RNA in cancer
Track 10-8
DNA sequencing in cancerous cells
Track 11: Overcoming Inequalities in Cancer Patients- A Case Study
Track 11-1
Cancer research: Clinical and experimental